Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years (Q34304485)

1 August 2017

title

Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years (English)

1 reference

Katherine A Lyseng-Williamson

1 August 2017

0 references

0 references

series ordinal

1

object named as

Katherine A Lyseng-Williamson

1 reference

1 August 2017

language of work or name

1 reference

1 November 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

29

1 reference

1 August 2017

issue

11

1 reference

1 August 2017

page(s)

911-923

1 reference

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Evidence-based recommendations for the assessment and management of sleep disorders in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Chronic insomnia, quality-of-life, and utility scores: comparison with good sleepers in a cross-sectional international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Use of sleep-promoting medications in nursing home residents : risks versus benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Comparative tolerability of newer agents for insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Use of non-benzodiazepine hypnotics in the elderly: are all agents the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Melatonin and melatonergic drugs on sleep: possible mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Melatonin and its analogs in insomnia and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Role of the melatonin system in the control of sleep: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Improvement of sleep quality in elderly people by controlled-release melatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Effects of prolonged-release melatonin and zolpidem on postural stability in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

The role of melatonin in patients with chronic kidney disease undergoing haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Facilitation of Benzodiazepine Discontinuation by Melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Alterations to Plasma Melatonin and Cortisol After Evening Alprazolam Administration in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-012-0018-Z

Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study

21 January 2018

1 reference

12 December 2020

Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance.

1 reference

12 December 2020

Melatonin rhythm abnormalities and sleep disorders in the elderly.

1 reference

12 December 2020

Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal

1 reference

12 December 2020

The state of insomnia and emerging trends

1 reference

12 December 2020

Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan.

1 reference

12 December 2020

Clinical guideline for the evaluation and management of chronic insomnia in adults.

1 reference

12 December 2020

Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs

1 reference

12 December 2020

Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials

1 reference

12 December 2020

[Therapy with melatonin does not suppress its endogenous production in healthy volunteers]

1 reference

12 December 2020

Melatonergic drugs in clinical practice

1 reference

12 December 2020

Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach

1 reference

12 December 2020

10.1007/S40266-012-0018-Z

Identifiers

DOI

1 reference

release_jknf6hskljdhncwdmvsd7vvafm

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jknf6hskljdhncwdmvsd7vvafm

24 November 2022

mapped directly with Wikidata item

1 reference